Sharing the stories behind scientific discovery. Each episode James O'Hanlon meets a different scientist and hears their 'behind the scenes' stories.
…
continue reading
Situ Science Podcasts
Join us for wide-ranging interviews with water monitoring professionals, who share everything from nitty-gritty project details to big-picture perspective. These conversations between guests and our own groundwater and surface water experts offer fascinating insight into the world of water science and the incredible work being done to protect our precious water resources. Presented to you by In-Situ. We specialize in the manufacture and design of equipment and software used to solve water mo ...
…
continue reading
Behind the Knife is the world’s #1 surgery podcast. From high-yield educational topics to interviews with leaders in the field, Behind the Knife delivers the information you need to know. Tune in for timely, relevant, and engaging content designed to help you DOMINATE THE DAY! Behind the Knife is more than a podcast. Visit www.behindtheknife.org to learn more.
…
continue reading
1
Remediation Deep Dive - PFAS Environmental Science in 7 Minutes or Less
Regenesis Bioremediation, Inc.
0
4
Welcome to Remediation Deep Dive — where key peer-reviewed publications on complex soil and groundwater challenges are discussed in 7 minutes or less. AI Technical Correspondents Max Phlux and Sandi Lohm break down the latest innovations in PFAS remediation offering listeners actionable insight to treat PFAS. Max and Sandi dive deep into the science and strategy behind managing forever chemicals using cutting edge approaches like in situ remediation with colloidal activated carbon to cost-ef ...
…
continue reading
As the leading authoritative, peer-reviewed audio source of oncology clinical news for clinicians and healthcare professionals, the AJO Podcast regularly brings you exclusive interviews with the world's leading researchers and clinicians responsible for pushing out the boundaries of science and practice. Medicine, screening, radiotherapy, surgery, clinical trials, cancer care, epidemiology and prevention are covered impartially to give busy cancer professionals access to conversational spoke ...
…
continue reading
1
Clinical Challenges in Trauma Surgery: Stabbed in the Back - Decision Making in a Penetrating Junctional Vascular Injury
33:53
33:53
Play later
Play later
Lists
Like
Liked
33:53
“It’s 5pm and your Consultant (attending) has headed off home. A patient arrives in the resuscitation room blood spurting from a stab wound in the armpit. Join Roisin – a junior Major Trauma fellow, Prash – a surgical trainee, Max – a senior trauma surgery fellow, and Chris – a Consultant trauma surgeon, as we talk through decision making from poin…
…
continue reading
1
Bart Neyns MD PhD: Patients with Recurrent Glioblastoma Lived Markedly Longer in Phase 1 Study of Intracranial Autologous Myeloid Dendritic Cell Therapy
10:55
10:55
Play later
Play later
Lists
Like
Liked
10:55
Audio Journal of Oncology interview with: Bart Neyns MD PhD, Vrije Universiteit Brussel, Faculty of Medicine and Pharmacy, Medical Oncology Department, Brussels, Belgium BARCELONA, Spain—Intracranial administration of autologous dendritic cells was combined with combination checkpoint inhibition in a phase 1 study of patients with recurrent gliobla…
…
continue reading
1
Meet your AI Examiner: Introducing Behind the Knife Oral Board Simulator
40:46
40:46
Play later
Play later
Lists
Like
Liked
40:46
Learn more: https://behindtheknifeoralboardsimulator.org/ It has arrived! Introducing Behind the Knife's Oral Board Simulator (beta version): Unlimited unique oral board scenarios Available 24/7 Diverse examiners Natural conversation Detailed, actionable feedback based on SCORE curriculum and American Board of Surgery grading scheme Try it for free…
…
continue reading
1
Victor Velculescu MD PhD: Ovarian Cancer Noninvasive Detection by Circulating DNA Fragmentome and Protein Biomarker AI Analysis
13:33
13:33
Play later
Play later
Lists
Like
Liked
13:33
An interview with: Victor Velculescu MD PhD, Co-director, Cancer Genetics & Epigenetics Program, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. SAN DIEGO, USA—A blood test using an artificial intelligence DNA pattern recognition system that brings earlier, more certain detection of o…
…
continue reading
Max and Sandi dive into the peer-reviewed article, “PFAS Monitored Retention: A Framework for Managing PFAS-Contaminated Groundwater Sites” by Adamson et al. (2025), exploring how PFAS Monitored Retention (PMR) and PFAS Enhanced Retention (PER) use physical and chemical processes to slow plume migration and reduce risk—offering a cost-effective opt…
…
continue reading
1
Timothy Yap MD PhD MBBS: Selective PARP1 Inhibitor Saruparib Clinical Promise in Solid Tumors with Homologous Recombination Repair Deficiency
18:45
18:45
Play later
Play later
Lists
Like
Liked
18:45
Audio Journal of Oncology: Sept 23rd, 2025 An interview with: Timothy Yap MD PhD MBBS, Professor of Investigational Cancer Therapeutics, Head of Clinical Development, Therapeutics Discovery Division, University of Texas MD Anderson Cancer Center, Houston, USA SAN DIEGO, USA—Breast, ovarian, pancreatic, prostate and other solid tumors with mutations…
…
continue reading
1
When Bad Outcomes Happen: A Lawyer on Liability, Litigation, and the Law
46:33
46:33
Play later
Play later
Lists
Like
Liked
46:33
Joining Dr. Scott Steele today on Behind the Knife is Steve Crandall, a former medical negligence DEFENSE lawyer who, for reasons we will discuss, switched sides and now represents the patient who is suing care providers. He is a founding partner of Crandall & Pera Law and also has been ranked as both one of the Top 5 Lawyers in Cleveland and Top 1…
…
continue reading
1
Stacey Kenfield ScD and June Chan ScD: Prostate Cancer Management: New Evidence of Big Benefit from Exercise:
10:28
10:28
Play later
Play later
Lists
Like
Liked
10:28
Interviews with: Stacey A. Kenfield ScD, Epidemiologist, Professor of Urology, Epidemiology and Biostatistics, and June Chan ScD, Cancer Epidemiologist, Department of Epibiostat and Urology, University of California San Francisco, California USA. SAN DIEGO, USA—Physical exercise keeps patients with prostate cancer alive longer, according to a combi…
…
continue reading
1
Jonathan T. Yang MD PhD: Radiosensitizer Shows Early Clinical Promise to Support Glioblastoma Radiotherapy
10:59
10:59
Play later
Play later
Lists
Like
Liked
10:59
An interview with Jonathan T. Yang MD PhD, Washington University, Seattle, USA, (Formerly of Memorial Sloan Kettering Cancer Center, New York.) SAN DIEGO, USA—An international phase one clinical study has found that a drug known to inhibit DNA damage repair was able to boost the efficacy of radiotherapy in patients being treated for their glioblast…
…
continue reading
1
USA vs. UK: ASGBI Ep. 6 - Current Challenges and Hopes for the Future of Surgical Training
36:42
36:42
Play later
Play later
Lists
Like
Liked
36:42
Welcome to the 6th episode of our BTK/ASGBI series! During this series, BTK fellow Agnes Premkumar and ASGBI hosts Jared Wohlgemut and Gita Lingam will compare and contrast various aspects of surgery between the United States and the United Kingdom, debating who does what better. In this episode, we delve into surgical training, current challenges,…
…
continue reading
1
Heather McArthur MD MPH: Adjuvant Checkpoint Inhibition: Did Not Improve Survival in Patients with Triple-Negative Breast Cancer
10:06
10:06
Play later
Play later
Lists
Like
Liked
10:06
An interview with: Heather McArthur MD MPH, Clinical Director Breast Cancer, Komen Distinguished Chair Clinical Breast Research, University of Texas Southwestern Medical Center, Dallas TX MILAN, Italy—Adjuvant therapy with a checkpoint inhibitor did not benefit patients with triple negative breast cancer in a big new study reported to the 14th Euro…
…
continue reading
1
Stefan Paepke MD: An End to “Jumping Breasts” with Mesh Supported Pre-Pectoral Breast Implants
10:48
10:48
Play later
Play later
Lists
Like
Liked
10:48
An interview with: Stefan Paepke MD, Interdisciplinary Breast Centre, Technical University of Munich, Germany, recorded at the 14th European Breast Cancer Conference, Milan, Italy. MILAN, Italy—Women who need surgical implants after their mastectomy for breast cancer could now benefit from mesh-supported prosthetics that bring high rates of satisfa…
…
continue reading
1
Sophie Bosma MD PhD:“Young Boost” Trial Finds Low-Dose Radiation Boost Optimal for Young Patients with High-Risk Early Breast Cancer
8:46
8:46
Play later
Play later
Lists
Like
Liked
8:46
An interview with Sophie Bosma MD PhD, from The Netherlands Cancer Institute, Amsterdam recorded at the 14th European Breast Cancer Conference in Milan. MILAN, Italy—The optimal radiation boost dose to protect young patients with early breast cancer has been investigated with ten years of follow up in the “Young Boost trial” conducted in the Nether…
…
continue reading
1
Journal Review in Colorectal Surgery: Management of Acute Uncomplicated Diverticulitis With or Without Antibiotics
30:29
30:29
Play later
Play later
Lists
Like
Liked
30:29
Why are we still treating acute uncomplicated diverticulitis with antibiotics? There is plenty of evidence from several randomized controlled trials demonstrating that symptomatic management alone yields similar results. If we should continue prescribing antibiotics for acute uncomplicated diverticulitis, which patients should undergo treatment and…
…
continue reading
1
Adri Voogd PhD: Ductal Carcinoma in Situ: Good Outcomes from Breast Conserving Therapy, but Benefits, Risks, Costs Still Need to be Optimized
15:54
15:54
Play later
Play later
Lists
Like
Liked
15:54
An interview with: Adri Voogd PhD, Associate Professor of Clinical Epidemiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands MILAN, Italy—Although outcomes following breast conserving surgery (with or without radiotherapy) for ductal carcinoma in situ (DCIS) are excellent, it is still not clear …
…
continue reading
1
Annemiek van Hemert MD PhD: “Breast Cancer: MARI Node Marker Helps Most Patients with Extensive Nodal Disease Safely Avoid Axillary Lymph Node Dissection”
10:16
10:16
Play later
Play later
Lists
Like
Liked
10:16
An interview with Annemiek van Hemert MD PhD, Surgical Oncology Department, Antoni van Leeuwenhoek-Netherlands Cancer Institute (AVL-NKI), Amsterdam Netherlands MILAN, Italy—Four out of five patients with extensive nodal spread of their breast cancer could be spared extensive axillary dissection, if a new method of marking lymph nodes is used. That…
…
continue reading
1
Journal Review in Surgical Education: Gossip in Residency
35:59
35:59
Play later
Play later
Lists
Like
Liked
35:59
Psst… wanna hear some tea? Join Drs. Maya Hunt, John Woodward, and Cait Silvestri as they discuss gossip - what it is, what it means, and how it can impact the surgical training environment. Joined by authors of a recent paper deconstructing gossip in surgical residency, Dr. Bobbi Ann Adair White and former CoSEF leader Dr. Joseph L’Huillier, the t…
…
continue reading
1
Tim Rattay MBChB PhD: Artificial Intelligence Tool Minimizes Arm Lymphedema After Breast Cancer Surgery and Radiotherapy
14:05
14:05
Play later
Play later
Lists
Like
Liked
14:05
An interview with: Tim Rattay MBChB PhD, Consultant Breast Surgeon, University Hospitals of Leicester, Associate Professor in Breast Surgery, Leicester Cancer Research Centre, University of Leicester, England, UK. A report from the 14th European Breast Cancer Conference, Milan, Italy MILAN, Italy—An artificial intelligence tool can predict the risk…
…
continue reading
Max and Sandi dive into the peer-reviewed article, “A Cost Comparison of Pump-and-Treat and In Situ Colloidal Activated Carbon for PFAS Plume Management” by Birnstingl and Wilson (2024), highlighting how CAC delivers decades-long PFAS containment at one-third the cost of pump-and-treat—without the waste, energy use, or long-term liabilities.…
…
continue reading
1
Yasmin Civil MD PhD: Low-Risk ER+ Breast Cancer: ABLATIVE Trial Finds Marked Benefit from MRI-Guided Single-Dose Neoadjuvant Partial Breast Radiotherapy
9:13
9:13
Play later
Play later
Lists
Like
Liked
9:13
An interview with Yasmin Civil MD PhD, UMC Hospital, Amsterdam, Netherlands. MILAN, Italy—Offering MRI-guided partial breast irradiation before surgery to patients with low-risk breast cancer could become the norm, according to Yasmin Civil MD PhD from the UMC Hospital in Amsterdam, who reported five-year results from the ABLATIVE trial of pre-oper…
…
continue reading
1
Clinical Challenges in Breast Surgery: The Management of Ductal Carcinoma In Situ (DCIS)
42:56
42:56
Play later
Play later
Lists
Like
Liked
42:56
Ductal carcinoma in situ (DCIS) represents a clinical crossroads in breast surgery—balancing the risks of over-treatment with the need to prevent invasive cancer. With new data from active monitoring trials, the pressure is on for surgeons to personalize care. Tune in to this essential episode to stay ahead of the curve on DCIS management and to he…
…
continue reading
1
Artificial Intelligence for the Clinician Episode 3: Basics of Machine Learning Statistics
25:15
25:15
Play later
Play later
Lists
Like
Liked
25:15
Welcome back our series on AI for the clinician! In this episode, we go over some basics of machine learning statistics with the goal to help you read and analyze contemporary studies. Some of this will be a review, and parts will be technical, but by the end we hope reading these studies is less daunting. Hosts: Ayman Ali, MD Ayman Ali is a Behind…
…
continue reading
1
Neo-Adjuvant Pembrolizumab Improved Outcomes with High-Risk ER+ HER2- Early Breast Cancer
8:55
8:55
Play later
Play later
Lists
Like
Liked
8:55
An interview with Heather McArthur MD MPH, Clinical Director of Breast Cancer, Komen Distinguished Chair in Clinical Breast Research, University of Texas Southwestern Medical Center, Dallas, USA MILAN, Italy—Patients with early breast cancer testing positive for estrogen receptor (ER+) and negative for human epidermal growth factor receptor 2 (HER2…
…
continue reading
1
Hot Topics from the Annals of Surgery Ep. 2: Academic Surgery
16:17
16:17
Play later
Play later
Lists
Like
Liked
16:17
In the second episode of this new collaboration between BTK and Annals of surgery, we discuss another hot topic: academic surgery. Specifically, we discuss dedicated research time for residents and how surgical leaders think about building the academic surgery enterprise. This discussion was inspired by a couple of recent papers in Annals of Surger…
…
continue reading
1
Laura J. van ’t Veer PhD: Triple Negative Early Breast Cancer Genetic Sub-Types Predict No Benefit from Neoadjuvant Pembrolizumab
15:48
15:48
Play later
Play later
Lists
Like
Liked
15:48
An interview with: Laura J. van ’t Veer PhD, Professor of Laboratory Medicine, Co-leader of the Breast Oncology Program, Director of Applied Genomics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. MILAN, Italy—Around 25 per cent of patients with newly-diagnosed triple negative breast cancer will not benef…
…
continue reading
1
I’ve Got 99 Problems, and a G Tube is One
25:47
25:47
Play later
Play later
Lists
Like
Liked
25:47
In this episode of Behind the Knife, Dr. Patrick Georgoff sits down with Dr. Keri Seymour and Dr. Joey Lew to tackle the complex world of gastrostomy tubes. What may seem like a routine and straightforward procedure is anything but—full of nuanced patient considerations, timing dilemmas, technical challenges, and potential complications that can tu…
…
continue reading
1
Clinical Challenges in Vascular Surgery: Type B Aortic Dissections (TBAD)
30:04
30:04
Play later
Play later
Lists
Like
Liked
30:04
A silent danger lurks within the descending thoracic aorta. While most Type B aortic dissections are managed medically, up to half of these patients will either require life-saving surgery or die within just five years. So how do we separate those who will quietly recover from those on the edge of catastrophe? How do we protect the spinal cord, bow…
…
continue reading
1
Érica A. Oliveira PhD: How to Overcome Drug Resistance: Patient Derived Organoids Study Finds Epigenetic Pathways in Colorectal Cancer
24:30
24:30
Play later
Play later
Lists
Like
Liked
24:30
Érica A. Oliveira PhD: How to Overcome Drug Resistance: Patient Derived Organoids Study Finds Epigenetic Pathways in Colorectal Cancer Interviews with: Érica A. Oliveira PhD, Senior Scientific Officer, Genomics and Evolutionary Dynamics, Institute of Cancer Research, Sutton, London UK And: Christopher Sng MD, Clinical Research Fellow, Institute of …
…
continue reading
